Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - CASH FROM OPERATIONS
Cash from Operations RARE - Ultragenyx Pharmaceutical Inc.
-475 M
LAST VALUE
-18.40%
2 YEAR CAGR
-10.32%
5 YEAR CAGR
-31.29%
10 YEAR CAGR